Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study

标题
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
作者
关键词
-
出版物
BLOOD
Volume -, Issue -, Pages blood-2018-09-876136
出版商
American Society of Hematology
发表日期
2018-12-04
DOI
10.1182/blood-2018-09-876136

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation